Novinky na Forexe

Japan Industrial Production Data Due On Tuesday

Japan Industrial Production Data Due On Tuesday

Japan will on Tuesday release final April figures for industrial production, highlighting a modest day for Asia-Pacific economic activity. In March, output was up 0.3 percent on month and down 1.7 percent on year, while capacity utilization sank 1.6 percent on month.
RTTNews | Pred 922 dňami
TSX Ends Sharply Lower As Stocks Tumble On Global Weakness

TSX Ends Sharply Lower As Stocks Tumble On Global Weakness

The Canadian market ended sharply lower on Monday, extending losses from the previous session, as rising worries about global economic slowdown, higher bond yields and looming interest rate hikes triggered heavy selling across the board.
RTTNews | Pred 922 dňami
European Stocks Close Sharply Lower On Recession Fears, Virus Jitters

European Stocks Close Sharply Lower On Recession Fears, Virus Jitters

European stocks tanked on Monday, extending losses from the previous session, as fears of a possible recession and news of a "ferocious" COVID-19 outbreak in Beijing's most populous district of Chaoyang sapped investors' appetite for riskier assets.
RTTNews | Pred 922 dňami
UK Q2 GDP To Fall 0.4% In Q2: NIESR

UK Q2 GDP To Fall 0.4% In Q2: NIESR

Chances of a UK recession increased with fall in economic output in April and the economy is likely to shrink 0.4 percent in the second quarter amid a similar size fall in the services output, the National Institute of Economic and Social Research said Monday. Official data released earlier on Monday showed that gross domestic product fell 0.3 percent in the month of April despite strength in private services sectors. In May, NIESR forecast UK growth at 3.5 percent this year. "Strong growth in retail, hospitality and other services suggests that some households may have been able to smooth their consumption in the face of the inflation shock," NIESR Principal Economist Rory Macqueen said. "Manufacturing appears to be suffering as a result of the impact of high petrol and energy, with declines in 8 out of 13 sub-sectors, but April's overall decline was principally driven by the winding-down of the Test and Trace programme, which had made significant positive contributions to GDP over most of the Covid-19 period"
RTTNews | Pred 923 dňami
more news
U.S. Dollar Higher On Aggressive Rate Hike Hopes

U.S. Dollar Higher On Aggressive Rate Hike Hopes

The U.S. dollar appreciated against its most major counterparts in the European session on Monday, as hot U.S. inflation data drove the treasury yields higher and raised expectations that the Federal Reserve will continue to tighten policy aggressively in the coming months.
RTTNews | Pred 923 dňami
Bay Street Seen Opening On Weak Note

Bay Street Seen Opening On Weak Note

Sharply lower Canadian and U.S. futures, weak global markets and falling commodities point to a gap down opening on Bay Street Monday morning.
RTTNews | Pred 923 dňami
Prologis To Acquire Duke Realty In All-stock Deal Valued At About $26 Bln

Prologis To Acquire Duke Realty In All-stock Deal Valued At About $26 Bln

Prologis, Inc. (PLD) and Duke Realty Corp. (DRE) announced Monday that the two companies have entered into a definitive merger agreement by which Prologis will acquire Duke Realty in an all-stock transaction, valued at approximately $26 billion, including the assumption of debt.
RTTNews | Pred 923 dňami
Mallinckrodt To Emerge From Chapter 11 In Coming Days

Mallinckrodt To Emerge From Chapter 11 In Coming Days

Mallinckrodt plc (MNKKQ) announced Monday that it expects to complete its reorganization process, emerge from Chapter 11 and complete the Irish Examinership proceedings in the coming days.
RTTNews | Pred 923 dňami
ImmunoGen, Oxford BioTherapeutics To Collaborate To Develop Novel Antibody-Drug Conjugates

ImmunoGen, Oxford BioTherapeutics To Collaborate To Develop Novel Antibody-Drug Conjugates

ImmunoGen Inc. (IMGN), a developer of antibody-drug conjugates (ADCs) for the treatment of cancer, announced Monday a multi-year collaboration to research novel, first-in-class ADCs with clinical stage oncology company Oxford BioTherapeutics (OBT), utilizing ImmunoGen's proprietary linker-payload technology directed to novel targets identified via OBT's proprietary OGAP discovery platform.
RTTNews | Pred 923 dňami

Stay up to date!

Add Správy to your browser

Extension Picture